Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Narrative)

v3.20.4
Commitments and Contingencies (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
May 01, 2020
$ / shares
shares
Nov. 30, 2019
USD ($)
Nov. 30, 2017
USD ($)
Nov. 30, 2016
USD ($)
ft²
Sep. 30, 2020
$ / shares
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2014
Payments of rent           $ 61,000    
Monthly lease payments           225,681 $ 201,256  
Alachua Facility [Member]                
Period of lease               5 years
Tampa Facility [Member]                
Period of lease   3 years   36 months        
Area of office space leased | ft²       2,207        
Lease expiry date       Feb. 29, 2020        
Minimum [Member] | Amended Lease Agreement [Member]                
Payments of rent           9,641    
Monthly lease payments           12,870    
Minimum [Member] | Tampa Facility [Member]                
Monthly lease payments   $ 4,524   $ 4,138        
Maximum [Member] | Tampa Facility [Member]                
Monthly lease payments   $ 4,800   $ 4,392        
2018 Warrants [Member]                
Warrants exercise price per share | $ / shares         $ 1.00      
Number of shares issued for warrants | shares         760,000      
Warrants to purchase | shares         4,294,500      
2019 Warrants [Member]                
Warrants exercise price per share | $ / shares         $ 0.90      
Number of shares issued for warrants | shares         4,882,114      
Warrants to purchase | shares         9,583,334      
Noachis Terra Inc. [Member]                
Payment for contingent consideration           542,263    
Noachis Terra Inc. [Member] | Warrants [Member]                
Payment for contingent consideration           1,220,781    
Stock Purchase Agreement [Member] | Warrants [Member] | Mr. Joseph Hernandez [Member] | Minimum [Member]                
Warrants exercise price per share | $ / shares $ 0.75              
Stock Purchase Agreement [Member] | Warrants [Member] | Mr. Joseph Hernandez [Member] | Maximum [Member]                
Warrants exercise price per share | $ / shares 0.90              
Stock Purchase Agreement [Member] | Warrant One [Member] | Mr. Joseph Hernandez [Member]                
Warrants exercise price per share | $ / shares $ 1.00              
Percentage of warrant exercise 45.00%              
Stock Purchase Agreement [Member] | Noachis Terra Inc. [Member] | Warrants [Member]                
Contingent consideration description i) twenty percent (20%) of the cash proceeds received by the Company upon exercise of the Company's warrants carrying an exercise price of $0.75 and $0.90 and (ii) forty-five percent (45%) of the cash proceeds received by the Company upon exercise of the Company's warrants carrying an exercise price of $1.00, in each case, for so long as the warrants remain outstanding.              
Warrants exercise price per share | $ / shares $ 1.25              
Percentage of warrant exercise 20.00%              
Warrants exercise term description The Company's previously issued warrants carrying an exercise price of $0.75 have expired by their terms. As a result, no additional consideration will be due to the former sole shareholder of NTI relating to these warrants.              
Warrants to purchase | shares 9,200,000              
Stock Purchase Agreement [Member] | Noachis Terra Inc. [Member] | Warrants [Member] | Mr. Joseph Hernandez [Member]                
Warrants exercise price per share | $ / shares $ 0.90              
Stock Purchase Agreement [Member] | Noachis Terra Inc. [Member] | Warrant One [Member]                
Percentage of warrant exercise 45.00%              
License Agreement [Member]                
Royalty expenses           30,000    
Reimbursement expenses           $ 11,739    
Agreement expiration term           20 years    
Lantibiotic Exclusive Channel Collaboration [Member]                
Royalty rate percentage description     The Lantibiotic ECC was amended to: (i) consolidate the development milestone payments into one payment of $25,000,000, being due six months after receiving FDA approval of a New Drug Application, (ii) reduce the sublicense revenue percentage we would have had to pay from 50% to 25% of sublicensing revenue, (iii) reduce the royalty rate from 25% of Product Profit to 10% of Net Sales, (iv) revise the form of milestone payments from being share based or cash at the Company's election to only cash, and (v) commit that Diligent Efforts (as defined in the Lantibiotic ECC) in pursuing the Lantibiotic Program would be deemed satisfied in 2018 provided that at least $1,200,000 was budgeted for the advancement of the Lantibiotic Program.          
Royalty payment of sublicenses percentage     25.00%          
Amount required to expended for advancement of lantibiotic program     $ 1,200,000          
Lantibiotic Exclusive Channel Collaboration [Member] | Net Sales [Member] | Amendment [Member]                
Royalty payment percentage     10.00%          
Lantibiotic Exclusive Channel Collaboration [Member] | Cost Of Revenue [Member]                
Royalty payment percentage     25.00%          
Lantibiotic Exclusive Channel Collaboration [Member] | Product Profit [Member]                
Reduction in royalty rate percentage     25.00%          
Lantibiotic Exclusive Channel Collaboration [Member] | Net Sales [Member]                
Reduction in royalty rate percentage     10.00%          
Lantibiotic Exclusive Channel Collaboration [Member] | New Drug Application [Member]                
Milestone payment under licensing agreement     $ 25,000,000          
Milestone measurement period     6 months          
Lantibiotic Exclusive Channel Collaboration [Member] | Regulatory Approval Milestone Event [Member]                
Milestone payment under licensing agreement     $ 25,000,000          
Milestone measurement period     6 months          
Lantibiotic Exclusive Channel Collaboration [Member] | New Indication Milestone Event [Member]                
Milestone payment under licensing agreement     $ 5,000,000          
Milestone measurement period     6 months          
Lantibiotic Exclusive Channel Collaboration [Member] | New Product Milestone Event [Member]                
Milestone payment under licensing agreement     $ 5,000,000          
Milestone measurement period     6 months          
Amended Lease Agreement [Member]                
Payments of rent           $ 165,000    
Amended Lease Agreement [Member] | Maximum [Member]                
Payments of rent           10,851    
Monthly lease payments           $ 13,338